Physician

Andrea D. Coviello, MD

According to 2025 Medicare claims, Andrea Coviello, MD (NPI: 1770590325) practices endocrinology in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (NPI: 1780669200; TIN: 561732213) and primary practice location at 27514-2286. Coviello is affiliated with the CHESS Genesis, LLC (ACO ID: D0237), participating under the REACH model.

Coviello's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 54 traditional Medicare patients, billed 210 HCPCS/CPT codes, and received $10,950 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 865 prescription claims across 154 beneficiaries totaling $499,486 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 51 claims. Open Payments data shows 16 records totaling $11,238. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $11,174 to $10,950. In contrast, Part D prescription costs have risen steadily, from $107,525 to $499,486. For DME billing, reported payments moved sharply higher in recent years, from $499 to $23,492.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	101	183	$11,174
2016	135	300	$18,267
2017	158	369	$24,584
2018	171	598	$36,023
2019	157	653	$36,924
2020	175	549	$29,663
2021	184	422	$30,286
2022	152	389	$23,420
2023	122	175	$10,553
2024	54	210	$10,950

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	64	808	$107,525
2016	72	543	$198,893
2017	111	822	$327,671
2018	138	1,050	$413,904
2019	133	1,066	$476,780
2020	143	1,105	$553,035
2021	150	1,232	$632,152
2022	185	1,302	$624,732
2023	200	1,036	$577,428
2024	154	865	$499,486

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	25	$376
2016	N/R	23	$429
2017	28	62	$924
2018	34	92	$3,736
2019	38	119	$5,475
2020	18	144	$12,290
2021	22	167	$22,285
2022	15	128	$21,215
2023	12	131	$24,420
2024	13	51	$22,327

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	20	26	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	48	91	$65
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	44	64	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	176	6,450	$238,582
Ozempic	Semaglutide	120	5,248	$167,758
Jardiance	Empagliflozin	31	1,470	$29,107
Humalog Kwikpen U-100	Insulin Lispro	14	897	$2,962
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	1,339	$2,518

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	13	51	$22,327

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$11,238	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrea D. Coviello, MD?

Tedicare shows public-source Medicare data for Andrea D. Coviello, MD (NPI 1770590325), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrea D. Coviello, MD have ACO affiliation data?

Andrea D. Coviello, MD is shown with ACO affiliation data for CHESS Genesis, LLC (REACH, ACO ID D0237).

What billing organization is linked to Andrea D. Coviello, MD?

Andrea D. Coviello, MD is linked to UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (billing NPI 1780669200) in the available physician profile data.

Does Andrea D. Coviello, MD have Open Payments data?

Andrea D. Coviello, MD has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.